The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Conformational motions and ligand-binding underlying gating and regulation in IP3R channel
Open accessPublished version of a preprint
Abstract
Inositol-1,4,5-trisphosphate receptors (IP 3 Rs) are activated by IP 3 and Ca 2+ and their gating is regulated by various intracellular messengers that finely tune the channel activity. Here, using single particle cryo-EM analysis we determined 3D structures of the nanodisc-reconstituted IP 3 R1 channel in two ligand-bound states. These structures provide unprecedented details governing binding of IP 3 , Ca 2+ and ATP, revealing conformational changes that couple ligand-binding to channel opening. Using a deep-learning approach and 3D variability analysis we extracted molecular motions of the key protein domains from cryo-EM density data. We find that IP 3 binding relies upon intrinsic flexibility of the ARM2 domain in the tetrameric channel. Our results highlight a key role of dynamic side chains in regulating gating behavior of IP 3 R channels. This work represents a stepping-stone to developing mechanistic understanding of conformational pathways underlying ligand-binding, activation and regulation of the channel.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Flagged first, then by citations
Research works printed but not linked: 82
- Bezprozvanny, I. Inositol 1,4,5-Tripshosphate Receptor, Calcium Signalling and Huntington’s Disease Vol. 45 (Springer, 2007).
- Foskett, J. K. Inositol trisphosphate receptor Ca2+ release channels in neurological diseases. Pflug. Arch. 460, 481–494 (2010). · DOI
- Hisatsune, C. & Mikoshiba, K. IP3 receptor mutations and brain diseases in human and rodents. J. Neurochem 141, 790–807 (2017). · DOI
- Prole, D. L. & Taylor, C. W. Inositol 1,4,5-trisphosphate receptors and their protein partners as signalling hubs. J Physiol. 594, 2849–2866 (2016). · DOI
- Alzayady, K. J. et al. Defining the stoichiometry of inositol 1,4,5-trisphosphate binding required to initiate Ca2+ release. Sci. Signal. 9, ra35 (2016). · DOI
- Bosanac, I., Michikawa, T., Mikoshiba, K. & Ikura, M. Structural insights into the regulatory mechanism of IP3 receptor. Biochim Biophys. Acta 1742, 89–102 (2004). · DOI
- Foskett, J. K., White, C., Cheung, K. H. & Mak, D. O. Inositol trisphosphate receptor Ca2+ release channels. Physiol. Rev. 87, 593–658 (2007). · DOI · Paper page
- Bezprozvanny, I., Watras, J. & Ehrlich, B. E. Bell-shaped calcium-response curves of Ins(1,4,5)P3- and calcium-gated channels from endoplasmic reticulum of cerebellum. Nature 351, 751–754 (1991). · DOI
- Foskett, J. K. & Daniel Mak, D. O. Regulation of IP3R channel gating by Ca2+ and Ca2+ binding proteins. Curr. Top. Membr. 66, 235–272 (2010). · DOI
- Wagner, L. E. 2nd & Yule, D. I. Differential regulation of the InsP(3) receptor type-1 and -2 single channel properties by InsP3, Ca2+ and ATP. J. Physiol. 590, 3245–3259 (2012). · DOI
- Betzenhauser, M. J., Wagner, L. E. 2nd, Park, H. S. & Yule, D. I. ATP regulation of type-1 inositol 1,4,5-trisphosphate receptor activity does not require walker A-type ATP-binding motifs. J. Biol. Chem. 284, 16156–16163 (2009). · DOI
- Betzenhauser, M. J. et al. ATP modulation of Ca2+ release by type-2 and type-3 inositol (1, 4, 5)-triphosphate receptors. Differing ATP sensitivities and molecular determinants of action. J. Biol. Chem. 283, 21579–21587 (2008). · DOI
- Hagar, R. E. & Ehrlich, B. E. Regulation of the type III InsP3 receptor by InsP3 and ATP. Biophys. J. 79, 271–278 (2000). · DOI
- Mak, D. O., McBride, S. & Foskett, J. K. Regulation by Ca2+ and inositol 1,4,5-trisphosphate InsP3 of single recombinant type 3 InsP3 receptor channels. Ca2+ activation uniquely distinguishes types 1 and 3 InsP3 receptors. J. Gen. Physiol. 117, 435–446 (2001). · DOI
- Mak, D. O., McBride, S. & Foskett, J. K. ATP regulation of type 1 inositol 1,4,5-trisphosphate receptor channel gating by allosteric tuning of Ca2+ activation. J. Biol. Chem. 274, 22231–22237 (1999). · DOI
- Fan, G. et al. & Serysheva, II. Gating machinery of InsP3R channels revealed by electron cryomicroscopy. Nature 527, 336–341 (2015). · DOI
- Fan, G. et al. Cryo-EM reveals ligand induced allostery underlying InsP3R channel gating. Cell Res. 28, 1158–1170 (2018). · DOI
- Paknejad, N. & Hite, R. K. Structural basis for the regulation of inositol trisphosphate receptors by Ca2+ and IP3. Nat. Struct. Mol. Biol. 25, 660–668 (2018). · DOI
- Azumaya, C. M., Linton, E. A., Risener, C. J., Nakagawa, T. & Karakas, E. Cryo-EM structure of human type-3 inositol triphosphate receptor reveals the presence of a self-binding peptide that acts as an antagonist. J. Biol. Chem. 295, 1743–1753 (2020). · DOI
- Baker, M. R. et al. Cryo-EM structure of type 1 IP3R channel in a lipid bilayer. Commun. Biol. 4, 625 (2021). · DOI
- Schmitz, E. A., Takahashi, H. & Karakas, E. Structural basis for activation and gating of IP3 receptors. Nat. Commun. 13, 1408 (2022). · DOI
- Chen, M. & Ludtke, S. J. Deep learning-based mixed-dimensional Gaussian mixture model for characterizing variability in cryo-EM. Nat. Methods 18, 930–936 (2021). · DOI
- Punjani, A. & Fleet, D. J. 3D variability analysis: resolving continuous flexibility and discrete heterogeneity from single particle cryo-EM. J. Struct. Biol. 213, 107702 (2021). · DOI
- Arige, V., et al. Functional determination of calcium binding sites required for the activation of inositol 1,4,5-trisphosphate receptors. Proc. Natl Acad. Sci. USA 119, e2209267119 (2022). · DOI
- Supattapone, S., Worley, P. F., Baraban, J. M. & Snyder, S. H. Solubilization, purification and characteriztion of an inositol triphosphate receptor. J. Biol. Chem. 263, 1530–1534 (1988). · DOI
- Maeda, N., Niinobe, M. & Mikoshiba, K. A cerebellar Purkinje cell marker P400 protein is an inositol 1,4,5-triphosphate (InsP3) receptor protein. Purification and characterization of InsP3 receptor complex. Embo J. 9, 61–67 (1990). · DOI
- Kaftan, E. J., Ehrlich, B. E. & Watras, J. Inositol 1,4,5-triphosphate (InsP3) and calcium interact to increase the dynamic range of InsP3 receptor-dependent calcium signaling. J. Gen. Physiol. 110, 529–538 (1997). · DOI
- Tu, H., Wang, Z., Nosyreva, E., De Smedt, H. & Bezprozvanny, I. Functional characterization of mammalian inositol 1,4,5-trisphosphate receptor isoforms. Biophys. J. 88, 1046–1055 (2005). · DOI
- Bosanac, I. et al. Structure of the inositol 1,4,5-trisphosphate receptor binding core in complex with its ligand. Nature 420, 696–700 (2002). · DOI
- Bosanac, I. et al. Crystal structure of the ligand binding suppressor domain of type 1 inositol 1,4,5-trisphosphate receptor. Mol. Cell 17, 193–203 (2005). · DOI
- Lin, C. C., Baek, K. & Lu, Z. Apo and InsP-bound crystal structures of the ligand-binding domain of an InsP receptor. Nat. Struct. Mol. Biol. 18, 1172–1174 (2011). · DOI
- Seo, M. D. et al. Structural and functional conservation of key domains in InsP3 and ryanodine receptors. Nature 483, 108–112 (2012). · DOI
- Wilcox, R. A., Primrose, W. U., Nahorski, S. R. & Challiss, R. A. New developments in the molecular pharmacology of the myo-inositol 1,4,5-trisphosphate receptor. Trends Pharm. Sci. 19, 467–475 (1998). · DOI
- Kozikowski, A. P. et al. Deoxygenated inositol 1,4,5-trisphosphate analogues and their interaction with metabolic enzymes. (1R,2R,4R)-cyclohexane-1,2,4-tris(methylenesulfonate): a potent selective 5-phosphatase inhibitor. J. Med. Chem. 36, 3035–3038 (1993). · DOI
- Yoshikawa, F. et al. Mutational analysis of the ligand binding site of the inositol 1,4,5- trisphosphate receptor. J. Biol. Chem. 271, 18277–18284 (1996). · DOI
- Mak, D.-O., McBride, S. & Foskett, J. K. Inositol 1,4,5-triphosphate activation of inositol triphosphate receptor Ca2+ channel by ligand tuning of Ca2+ inhibition. Proc. Natl Acad. Sci. USA 95, 15821–15825 (1998). · DOI
- Mak, D. O., McBride, S. M., Petrenko, N. B. & Foskett, J. K. Novel regulation of calcium inhibition of the inositol 1,4,5-trisphosphate receptor calcium-release channel. J. Gen. Physiol. 122, 569–581 (2003). · DOI
- Marchant, J. S. & Taylor, C. W. Cooperative activation of IP3 receptors by sequential binding of IP3 and Ca2+ safeguards against spontaneous activity. Curr. Biol. 7, 510–518 (1997). · DOI
- Baker, M. R., Fan, G. & Serysheva, I. I. Structure of IP3R channel: high-resolution insights from cryo-EM. Curr. Opin. Struct. Biol. 46, 38–47 (2017). · DOI
- Du, G. G. & MacLennan, D. H. Functional consequences of mutations of conserved, polar amino acids in transmembrane sequences of the Ca2+ release channel (ryanodine receptor) of rabbit skeletal muscle sarcoplasmic reticulum. J. Biol. Chem. 273, 31867–31872 (1998). · DOI
- Miyakawa, T. et al. Ca2+-sensor region of IP3 receptor controls intracellular Ca2+ signaling. Embo J. 20, 1674–1680 (2001). · DOI
- Sienaert, I. et al. Localization and function of a calmodulin-apocalmodulin-binding domain in the N-terminal part of the type 1 inositol 1,4,5-trisphosphate receptor. Biochem J. 365, 269–277 (2002). · DOI
- Terry, L. E., Alzayady, K. J., Furati, E. & Yule, D. I. Inositol 1,4,5-trisphosphate receptor mutations associated with human disease. Messenger (Los Angel) 6, 29–44 (2018).
- Mak, D. O., McBride, S. & Foskett, J. K. ATP-dependent adenophostin activation of inositol 1,4,5-trisphosphate receptor channel gating. Kinetic implications for the durations of calcium puffs in cells. J. Gen. Physiol. 117, 299–314 (2001). · DOI
- Mak, D. O., McBride, S. & Foskett, J. K. Atp regulation of recombinant type 3 inositol 1,4,5-trisphosphate receptor gating. J. Gen. Physiol. 117, 447–456 (2001). · DOI
- Maes, K. et al. Mapping of the atp-binding sites on inositol 1,4,5-trisphosphate receptor type 1 and type 3 homotetramers by controlled proteolysis and photoaffinity labeling. J. Biol. Chem. 276, 3492–3497 (2001). · DOI
- Wierenga, R. K. & Hol, W. G. Predicted nucleotide-binding properties of p21 protein and its cancer-associated variant. Nature 302, 842–844 (1983). · DOI
- Fulton, J., Heald, S., Badayl, Y. & Simonson, J. Understanding the effects of concentration on the solvation structure of Ca2+ in aqueous solution. I: The perspective on local structure from EXAFS and XANES. J. Phys. Chem. 107, 4688–4696 (2003). · DOI
- Tang, L. et al. W. A. Structural basis for Ca2+ selectivity of a voltage-gated calcium channel. Nature 505, 56–61 (2014). · DOI
- Sun, J. & MacKinnon, R. Structural basis of human KCNQ1 Modulation and Gating. Cell 180, e349 (2020). · DOI
- Zhao, C. & MacKinnon, R. Molecular structure of an open human KATP channel. Proc. Natl Acad. Sci. USA 118, e2112267118 (2021). · DOI
- Park, E. & MacKinnon, R. Structure of the CLC-1 chloride channel from Homo sapiens. eLife 7, e36629 (2018). · DOI · Paper page
- Lee, C. H. & MacKinnon, R. Activation mechanism of a human SK-calmodulin channel complex elucidated by cryo-EM structures. Science 360, 508–513 (2018). · DOI
- Montero, M. et al. Monitoring dynamic changes in free Ca2+ concentration in the endoplasmic reticulum of intact cells. EMBO J. 14, 5467–5475 (1995). · DOI
- Missiaen, L., De Smedt, H., Parys, J. B. & Casteels, R. Co-activation of inositol trisphosphate-induced Ca2+ release by cytosolic Ca2+ is loading-dependent. J. Biol. Chem. 269, 7238–7242 (1994). · DOI
- Combettes, L., Cheek, T. R. & Taylor, C. W. Regulation of inositol trisphosphate receptors by luminal Ca2+ contributes to quantal Ca2+ mobilization. EMBO J. 15, 2086–2093 (1996). · DOI
- Hayashi, S. et al. Comprehensive investigation of CASK mutations and other genetic etiologies in 41 patients with intellectual disability and microcephaly with pontine and cerebellar hypoplasia (MICPCH). PloS One 12, e0181791 (2017). · DOI
- Zambonin, J. L. et al. Spinocerebellar ataxia type 29 due to mutations in ITPR1: a case series and review of this emerging congenital ataxia. Orphanet J. Rare Dis. 12, 121 (2017). · DOI
- Ionescu, L. et al. Graded recruitment and inactivation of single InsP3 receptor Ca2+-release channels: implications for quantal [corrected] Ca2+release. J. Physiol. 573, 645–662 (2006). · DOI
- Ionescu, L. et al. Mode switching is the major mechanism of ligand regulation of InsP3 receptor calcium release channels. J. Gen. Physiol. 130, 631–645 (2007). · DOI
- Rosales, R. A., Fill, M. & Escobar, A. L. Calcium regulation of single ryanodine receptor channel gating analyzed using HMM/MCMC statistical methods. J. Gen. Physiol. 123, 533–553 (2004). · DOI
- Chakrapani, S. et al. On the structural basis of modal gating behavior in K+ channels. Nat. Struct. Mol. Biol. 18, 67–74 (2011). · DOI
- Popescu, G., Robert, A., Howe, J. R. & Auerbach, A. Reaction mechanism determines NMDA receptor response to repetitive stimulation. Nature 430, 790–793 (2004). · DOI
- Rothberg, B. S., Bello, R. A., Song, L. & Magleby, K. L. High Ca2+ concentrations induce a low activity mode and reveal Ca2+-independent long shut intervals in BK channels from rat muscle. J. Physiol. 493, 673–689 (1996). · DOI
- Park, H. S., Betzenhauser, M. J., Won, J. H., Chen, J. & Yule, D. I. The type 2 inositol (1,4,5)-trisphosphate (InsP3) receptor determines the sensitivity of InsP3-induced Ca2+ release to ATP in pancreatic acinar cells. J. Biol. Chem. 283, 26081–26088 (2008). · DOI
- Chandrasekhar, R., Alzayady, K. J., Wagner, L. E. 2nd & Yule, D. I. Unique regulatory properties of heterotetrameric inositol 1,4,5-trisphosphate receptors Revealed by studying concatenated receptor constructs. J. Biol. Chem. 291, 4846–4860 (2016). · DOI
- Ludtke, S. J., Tran, T. P., Ngo, Q. T., Moiseenkova-Bell, V. Y., Chiu, W. & Serysheva, I. I. Flexible architecture of IP3R1 by Cryo-EM. Structure 19, 1192–1199 (2011). · DOI
- Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331–332 (2017). · DOI
- Bell, J. M., Chen, M., Durmaz, T., Fluty, A. C. & Ludtke, S. J. New software tools in EMAN2 inspired by EMDatabank map challenge. J. Struct. Biol. 204, 283–290 (2018). · DOI
- Zhang, K. Gctf: Real-time CTF determination and correction. J. Struct. Biol. 193, 1–12 (2016). · DOI
- Scheres, S. H. RELION: Implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 180, 519–530 (2012). · DOI · Paper page
- Rosenthal, P. B. & Henderson, R. Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. J. Mol. Biol. 333, 721–745 (2003). · DOI · Paper page
- Kucukelbir, A., Sigworth, F. J. & Tagare, H. D. Quantifying the local resolution of cryo-EM density maps. Nat. Methods 11, 63–65 (2014). · DOI
- Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017). · DOI · Paper page
- Pettersen, E. F. et al. UCSF Chimera–a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004). · DOI
- Hryc, C. F. & Baker, M. L. Beyond the backbone: the next generation of pathwalking utilities for model building in CryoEM density maps. Biomolecules 12, 773 (2022). · DOI
- Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774–797 (2007). · DOI
- Pettersen, E. F. et al. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. 30, 70–82 (2021). · DOI
- Laskowski, R. A. & Swindells, M. B. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J. Chem. Inf. modeling 51, 2778–2786 (2011). · DOI
- Smart, O. S., Goodfellow, J. M. & Wallace, B. A. The pore dimensions of gramicidin A. Biophys. J. 65, 2455–2460 (1993). · DOI
- Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph 14, 33–38 (1996). 27-38. · DOI · Paper page
- Alzayady, K. J., Chandrasekhar, R. & Yule, D. I. Fragmented inositol 1,4,5-trisphosphate receptors retain tetrameric architecture and form functional Ca2+ release channels. J. Biol. Chem. 288, 11122–11134 (2013). · DOI
Metadata
- Authors
- Fan, G., Baker, M. R., Terry, L. E., Arige, V., Chen, M., Seryshev, A. B., Baker, M. L., Ludtke, S. J., Yule, D. I., & Serysheva, I. I.
- Affiliations
- The University of Texas Health Science Center at Houston (US)
- University of Rochester Medicine (US)
- Baylor College of Medicine (US)
- Corresponding author
- Yule, David I.
- Serysheva, Irina I.
- ORCID
- Venue
- Nature Communications
- Published
- 2022-11-14
- Volume
- 13
- Issue
- 1
- Pages
- 6942-6942
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC9663519
- OpenAlex
- W4308963932
- Cited by
- 52
- References
- 1
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 11 · 2023: 18 · 2022: 1
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Nature Communications (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Digital Commons-TMC (Texas Medical Center) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM072804, R01GM080139)
- U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (DE019245)
- American Heart Association (18CDA34110086)
- Welch Foundation (AU-2014-20190330, AU-2014-20220331)
- Cancer Prevention and Research Institute of Texas (RP190602)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
- Keywords
- IP3 receptor, IP3R1, channel gating, ligand binding, conformational dynamics, IP3 binding, calcium binding, ATP binding, nanodisc reconstitution, deep learning, intracellular calcium signaling, ion channel structure
- MeSH terms
- Protein Domains, Calcium, Ligands, Inositol 1,4,5-Trisphosphate, Calcium Signaling, Inositol 1,4,5-Trisphosphate Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review